VYNE Therapeutics Inc. Common Stock (VYNE)
Since Aug 12, 2021, VYNE Therapeutics Inc. Common Stock (VYNE) has reported earnings 18 times. On average the shares move ±95.52% post-earnings, with a positive reaction 61.1% of the time. Its largest post-earnings gain was +1606.67% (Mar 09, 2023) and its largest decline was -31.38% (Aug 12, 2021). The next earnings report is predicted for 2026-08-14 (approximate).
Earnings reactions
How VYNE moved on each past earnings report.
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±95.52%
Positive %
61.1%
Negative %
38.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Nov 06, 2025 | ☀ PRE | +5.36% | open_in_new |
| Aug 14, 2025 | ☀ PRE | -1.27% | open_in_new |
| May 08, 2025 | ☀ PRE | -3.36% | open_in_new |
| Mar 06, 2025 | ☀ PRE | +0% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±95.52%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260721 | open_in_new SEC.gov |
| 8-K | 20260720 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260717 | open_in_new SEC.gov |
| 425 | 20260714 | open_in_new SEC.gov |
| 8-K | 20260714 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260714 | open_in_new SEC.gov |
| 425 | 20260710 | open_in_new SEC.gov |
| 8-K | 20260710 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
Frequently asked about VYNE earnings
When does VYNE Therapeutics Inc. Common Stock report earnings next? expand_more
VYNE Therapeutics Inc. Common Stock (VYNE)'s next earnings date is approximate for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does VYNE stock move after earnings? expand_more
Over 18 reports, VYNE has moved an average of ±95.52% the session after earnings, closing higher 61.1% of the time.
What was VYNE's biggest post-earnings move? expand_more
VYNE's largest post-earnings gain on record was +1606.67% on Mar 09, 2023, and its largest decline was -31.38% on Aug 12, 2021.
Where can I find VYNE Therapeutics Inc. Common Stock's SEC filings? expand_more
All of VYNE Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right